Reversible inhibition of cellular metabolism by ribavirin.

Enhancement of activity against influenza viruses by combinations of antiviral agents. Antimicrob Agents Chemother (1980) 1.28

Effect of ribavirin on macromolecular synthesis in vesicular stomatitis virus-infected cells. Antimicrob Agents Chemother (1986) 1.06

Effect of phosphorylated ribavirin on vesicular stomatitis virus transcription. Antimicrob Agents Chemother (1988) 1.03

Antiviral therapy: current concepts and practices. Clin Microbiol Rev (1992) 0.96

Reversible effects on cellular metabolism and proliferation by trisodium phosphonoformate. Antimicrob Agents Chemother (1978) 0.93

Broad-spectrum synergistic antiviral activity of selenazofurin and ribavirin. Antimicrob Agents Chemother (1984) 0.85

Inhibition of lymphocyte proliferative responses by ribavirin. Infect Immun (1980) 0.85

Inhibitory effect of a nucleotide analog on infectious salmon anemia virus infection. J Virol (2011) 0.83

Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide. Science (1972) 7.74

Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent. Proc Natl Acad Sci U S A (1973) 4.36

The relationship between the metabolism of ribavirin and its proposed mechanism of action. Ann N Y Acad Sci (1977) 1.79

The selective inhibition of viral DNA synthesis by chemotherapeutic agents: an indicator of clinical usefulness? Ann N Y Acad Sci (1977) 1.65

Virazole (1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide; a cytostatic agent. Biochem Pharmacol (1977) 1.40

Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate. Antimicrob Agents Chemother (1977) 2.71

Random albumin/creatinine ratio for quantification of proteinuria in manifest pre-eclampsia. BJOG (2006) 2.13

Trisodium phosphonoformate, a new antiviral compound. Science (1978) 2.13

Antiviral effects of phosphonoformate (PFA, foscarnet sodium). Pharmacol Ther (1982) 2.04

Inhibition of HTLV-III/LAV replication by foscarnet. Biochem Pharmacol (1985) 1.97

Congenital hypothyroidism in Sweden. Incidence and age at diagnosis. Acta Paediatr Scand (1978) 1.94

HIV-1-specific reverse transcriptase inhibitors show differential activity against HIV-1 mutant strains containing different amino acid substitutions in the reverse transcriptase. Virology (1993) 1.92

Incidence of soccer injuries and their relation to training and team success. Am J Sports Med (1983) 1.88

Identification of the in vitro translation products of adenovirus mRNA by immunoprecipitation. J Virol (1975) 1.74

Hypocalcemia and parathyroid hormone secretion in critically ill patients. Crit Care Med (2000) 1.73

Mode of action, toxicity, pharmacokinetics, and efficacy of some new antiherpesvirus guanosine analogs related to buciclovir. Antimicrob Agents Chemother (1986) 1.71

Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors. Proc Natl Acad Sci U S A (1995) 1.69

Turnover of nontypable Haemophilus influenzae in the nasopharynges of healthy children. J Clin Microbiol (1989) 1.66

Enzymatic synthesis of deoxyribonucleotides. X. Reduction of purine ribonucleotides; allosteric behavior and substrate specificity of the enzyme system from Escherichia coli B. J Biol Chem (1966) 1.64

Significance of ribonucleotide reduction in the biosynthesis of deoxyribonucleotides in Escherichia coli. Eur J Biochem (1967) 1.63

Increased activity in left ventricular receptors during hemorrhage or occlusion of caval veins in the cat. A possible cause of the vaso-vagal reaction. Acta Physiol Scand (1972) 1.61

Effects of warming up, massage, and stretching on range of motion and muscle strength in the lower extremity. Am J Sports Med (1983) 1.58

Replication of poliovirus RNA studied by gel filtration and electrophoresis. Eur J Biochem (1969) 1.58

Genotyping is a valuable diagnostic complement to neonatal screening for congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency. J Clin Endocrinol Metab (1999) 1.56

Biochemical and biological characteristics of carbethoxylated poliovirus and viral RNA. Biochim Biophys Acta (1970) 1.54

Glutathione synthetase deficiency, an inborn error of metabolism involving the gamma-glutamyl cycle in patients with 5-oxoprolinuria (pyroglutamic aciduria). Proc Natl Acad Sci U S A (1974) 1.51

Arthritis in DBA/1 mice induced with passively transferred type II collagen immune serum. Immunohistopathology and serum levels of anti-type II collagen auto-antibodies. Scand J Immunol (1990) 1.51

The odontogenic keratocyst: a benign cystic tumor? J Oral Maxillofac Surg (1984) 1.51

RNA ligase activity in phage-infected bacteria and animal cells. Eur J Biochem (1974) 1.50

Influence of cells and virus multiplicity on the inhibition of herpesviruses with acycloguanosine. Intervirology (1980) 1.50

Primary Sjögren's syndrome in patients with multiple sclerosis. Neurology (1992) 1.49

Active smoking and a history of smoking are associated with enhanced prostaglandin F(2alpha), interleukin-6 and F2-isoprostane formation in elderly men. Atherosclerosis (2005) 1.49

Characterization of EBV-carrying B-cell populations in healthy seropositive individuals with regard to density, release of transforming virus and spontaneous outgrowth. Int J Cancer (1987) 1.48

Identification of the stable free radical tyrosine residue in ribonucleotide reductase. EMBO J (1986) 1.47

Automated pre-ejection period variation indexed to tidal volume predicts fluid responsiveness after cardiac surgery. Acta Anaesthesiol Scand (2009) 1.46

Comparison of the substrate specificities of human thymidine kinase 1 and 2 and deoxycytidine kinase toward antiviral and cytostatic nucleoside analogs. Biochem Biophys Res Commun (1991) 1.44

The European Union Directive on Clinical Research: present status of implementation in EU member states' legislations with regard to the incompetent patient. Intensive Care Med (2005) 1.42

Uncompensated blood loss is not tolerated during acute normovolemic hemodilution in anesthetized pigs. Anesth Analg (1998) 1.42

Binding of histidine to tobacco mosaic virus RNA. Biochem Biophys Res Commun (1972) 1.40

Isolation and characterization of calf liver thioredoxin. J Biol Chem (1974) 1.39

Altered brain white matter integrity in healthy carriers of the APOE epsilon4 allele: a risk for AD? Neurology (2006) 1.38

Gastrointestinal transit of amoxicillin modified-release tablets and a placebo tablet including pharmacokinetic assessments of amoxicillin. Scand J Gastroenterol (1996) 1.38

Intra- and inter-tester reliability and reference values for hand strength. J Rehabil Med (2001) 1.37

Regional variations of iodine nutrition and thyroid function during the neonatal period in Europe. Biol Neonate (1986) 1.37

Evidence for two different classes of redox-active cysteines in ribonucleotide reductase of Escherichia coli. J Biol Chem (1989) 1.36

Missense mutations in the human glutathione synthetase gene result in severe metabolic acidosis, 5-oxoprolinuria, hemolytic anemia and neurological dysfunction. Hum Mol Genet (1997) 1.36

Antiherpetic activity and mechanism of action of 9-(4-hydroxybutyl)guanine. Antiviral Res (1983) 1.35

Replicative structures of poliovirus RNA in vivo. J Mol Biol (1971) 1.35

Pyrophosphate analogues as inhibitors of herpes simplex virus type 1 DNA polymerase. Biochim Biophys Acta (1980) 1.34

Inhibition of gamma-glutamylcysteine synthetase by cystamine: an approach to a therapy of 5-oxoprolinuria (pyroglutamic aciduria). Biochem Biophys Res Commun (1977) 1.34

Antibody dependent cytolytic effector lymphocytes (K cells) in human blood. J Reticuloendothel Soc (1975) 1.33

Pyrophosphate analogues as inhibitors of DNA polymerases of cytomegalovirus, herpes simplex virus and cellular origin. Biochim Biophys Acta (1982) 1.33

The timing of glucocorticoid administration in rheumatoid arthritis. Ann Rheum Dis (1997) 1.33

Characteristics of herpesvirus mutants resistant to phosphonoformate and phosphonoacetate. Antimicrob Agents Chemother (1979) 1.31

PPi analogs as inhibitors of human T-lymphotropic virus type III reverse transcriptase. Antimicrob Agents Chemother (1986) 1.30

Inhibition of the reverse transcriptase from HIV by 3'-azido-3'-deoxythymidine triphosphate and its threo analogue. Antiviral Res (1987) 1.29

The COPE index--a first stage assessment of negative impact, positive value and quality of support of caregiving in informal carers of older people. Aging Ment Health (2003) 1.28

Enzymatic synthesis of deoxyribonucleotides. IX. Allosteric effects in the reduction of pyrimidine ribonucleotides by the ribonucleoside diphosphate reductase system of Escherichia coli. J Biol Chem (1966) 1.27

Comparison of the therapeutic effects of five antiviral agents on cutaneous herpesvirus infection in guinea pigs. Arch Virol (1978) 1.26

In vivo and in vitro synthesis of adenovirus type 2 early proteins. J Virol (1976) 1.26

Nucleic acid hybridization, a method to determine effects of antiviral compounds on herpes simplex virus type 1 DNA synthesis. Antiviral Res (1984) 1.25

Altered deactivation in individuals with genetic risk for Alzheimer's disease. Neuropsychologia (2008) 1.25

Intravenous foscarnet for the treatment of severe cytomegalovirus infection in allograft recipients. Scand J Infect Dis (1985) 1.25

Inhibiting effect of (RS)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine on varicella-zoster virus replication in cell culture. Antimicrob Agents Chemother (1987) 1.25

Analysis of oligonucleotide probe affinities using surface plasmon resonance: a means for mutational scanning. Anal Biochem (1997) 1.24

Glycerol production in subcutaneous adipose tissue in lean and obese humans. J Clin Invest (1992) 1.24

Human immunodeficiency virus type 1 (HIV-1) strains selected for resistance against the HIV-1-specific [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro- 5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)]-beta-D-pentofurano syl (TSAO) nucleoside analogues retain sensitivity to HIV-1-specific nonnucleoside inhibitors. Proc Natl Acad Sci U S A (1993) 1.24

Incidence of congenital hypothyroidism: retrospective study of neonatal laboratory screening versus clinical symptoms as indicators leading to diagnosis. Br Med J (Clin Res Ed) (1984) 1.23

Phosphonoformate inhibits reverse transcriptase. J Gen Virol (1979) 1.22

Evaluation of Gentian cystatin C reagent on Abbott Ci8200 and calculation of glomerular filtration rate expressed in mL/min/1.73 m(2) from the cystatin C values in mg/L. Scand J Clin Lab Invest (2007) 1.21

Critical determinants of antiherpes efficacy of buciclovir and related acyclic guanosine analogs. Antiviral Res (1987) 1.21

T and B cell responses of Plasmodium falciparum malaria-immune individuals to synthetic peptides corresponding to sequences in different regions of the P. falciparum antigen Pf155/RESA. J Immunol (1989) 1.21

Studies on left ventricular receptors, signalling in non-medullated vagal afferents. Acta Physiol Scand (1972) 1.21

Design and evaluation of pilicides: potential novel antibacterial agents directed against uropathogenic Escherichia coli. Chembiochem (2001) 1.20

Therapeutic effect of trisodium phosphonoformate on cutaneous herpesvirus infection in guinea pigs. Antimicrob Agents Chemother (1978) 1.20

Study of Fab and F(ab') 2 from rabbit IgG for capacity to induce lymphocyte-mediated target cell destruction in vitro. Int Arch Allergy Appl Immunol (1972) 1.20

Metabolism and mode of action of (R)-9-(3,4-dihydroxybutyl)guanine in herpes simplex virus-infected vero cells. J Biol Chem (1986) 1.20

Pyroglutamic aciduria (5-oxoprolinuria), an inborn error in glutathione metabolism. Pediatr Res (1974) 1.19

The relationship between active constriction and passive recoil of the veins at various distending pressures. Acta Physiol Scand (1968) 1.19

Routine oxytocin in the third stage of labour: a placebo controlled randomised trial. Br J Obstet Gynaecol (1997) 1.19

9-(3,4-dihydroxybutyl)guanine, a new inhibitor of herpesvirus multiplication. Antimicrob Agents Chemother (1983) 1.18

Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome? Ann Rheum Dis (2000) 1.16

Detection of antigen-antibody interactions by surface plasmon resonance. Application to epitope mapping. J Mol Recognit (1991) 1.16

Inhibition of cytomegalovirus late antigens by phosphonoformate. Intervirology (1980) 1.15

Mental development in congenital hypothyroidism after neonatal screening. Arch Dis Child (1987) 1.15

Lower extremity goniometric measurements: a study to determine their reliability. Arch Phys Med Rehabil (1982) 1.14

Immunohistochemical localisation of tissue plasminogen activator and urokinase in the vessel wall. J Clin Pathol (1985) 1.13

Corticosteroid treatment of experimental arthritis retards cartilage destruction as determined by histology and serum COMP. Rheumatology (Oxford) (2004) 1.13

Inhibition of human immunodeficiency virus in vitro by combinations of 3'-azido-3'-deoxythymidine and foscarnet. Antimicrob Agents Chemother (1989) 1.13

Cytotoxicity of human lymphocytes induced by rabbit antibodies to chicken erythrocytes. Inhibition by normal IgG and by human myeloma proteins of different IgG subclasses. Immunology (1973) 1.11

Genetic regulation of human anti-malarial antibodies in twins. Proc Natl Acad Sci U S A (1992) 1.11

Descriptions of functioning and health and relations to a gross motor classification in adults with cerebral palsy. Disabil Rehabil (2004) 1.11

Ribonucleotide reductase rom regenerating rat liver. Eur J Biochem (1969) 1.10

Therapeutic effects of foscarnet sodium and acyclovir on cutaneous infections due to herpes simplex virus type 1 in guinea pigs. J Infect Dis (1982) 1.10